HappeningToo topic

Canagliflozin reports

Browse community reports connected to Canagliflozin. These reports can show that other people are describing similar experiences, but they do not prove that Canagliflozin caused a symptom or reaction.

⚕️ Medicine safety note

Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.

31 problems

Abdominal Discomfort while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and abdominal discomfort appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain Upper while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and abdominal pain upper appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Abdominal Pain while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and abdominal pain appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Acid reflux while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and acid reflux appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Alopecia while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and alopecia appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Back Pain while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and back pain appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Constipation while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and constipation appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Cough while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and cough appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Decreased Appetite while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and decreased appetite appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dehydration while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and dehydration appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Diarrhea while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and diarrhea appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Dizziness while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and dizziness appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Excessive sweating while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and excessive sweating appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Fatigue while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and fatigue appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Feeling Abnormal while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and feeling abnormal appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Headache while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and headache appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hives while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and hives appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Hypotension while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and hypotension appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Insomnia while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and insomnia appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Itching while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and itching appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Malaise while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and malaise appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Muscle Spasms while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and muscle spasms appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Nausea while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and nausea appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Pain while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and pain appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Rash while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and rash appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Shortness of breath while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and shortness of breath appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Thirst while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and thirst appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Vomiting while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and vomiting appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weakness while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and weakness appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Decreased while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and weight decreased appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →

Weight Increased while using Canagliflozin

FDA FAERS contains adverse-event reports in which Canagliflozin and weight increased appear together. This does not establish that Canagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.

View reports →